Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Missense CACNA1A mutation causing episodic ataxia type 2.

C Denier1, A Ducros, A Durr

  • 1INSERM EPI 99-21, Faculté de Médecine Lariboisière, 10, Avenue de Verdun, 75010 Paris, France.

Archives of Neurology
|February 15, 2001
PubMed
Summary

A novel CACNA1A missense mutation, Glu 1757 Lys, was identified in a family with episodic ataxia type 2 (EA2). This finding expands understanding of CACNA1A gene mutations and their link to neurological disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study.

Muscle & nerve·2026
Same author

Lessons learned from 30 years of presymptomatic testing in Huntington Disease.

Revue neurologique·2025
Same author

Migraine management in France: Practices of general practitioners and neurologists.

Revue neurologique·2025
Same author

French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.

Revue neurologique·2025
Same author

Migraine treatment: Position paper of the French Headache Society.

Revue neurologique·2024
Same author

Congenital myasthenic syndromes by Epsilon subunit mutations: Phenotypic profiles of 17 Algerian families.

Revue neurologique·2024

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Episodic ataxia type 2 (EA2) is an autosomal dominant disorder.
  • It is characterized by recurrent, acetazolamide-responsive cerebellar ataxia spells.
  • The CACNA1A gene, encoding a calcium channel subunit, is implicated in EA2.

Purpose of the Study:

  • To characterize a novel CACNA1A mutation in an EA2 family.
  • To delineate clinical features of EA2.
  • To investigate genotype-phenotype correlations in EA2.

Main Methods:

  • Screening of all 47 exons of the CACNA1A gene.
  • Utilized single-strand conformer polymorphism and sequencing analysis.
  • Compared mutation presence against 200 control chromosomes.

Related Experiment Videos

Main Results:

  • Identified a CACNA1A missense mutation: Glu 1757 Lys.
  • The mutation was absent in controls.
  • Predicted to cause an amino acid substitution in a critical functional domain of the calcium channel.

Conclusions:

  • The Glu 1757 Lys mutation is likely pathogenic, causing episodic ataxia.
  • The family's phenotype is consistent with EA2, with a slightly later onset.
  • Further research is needed for comprehensive genotype-phenotype correlations in CACNA1A mutations.